Skip to main content
  • Saved

made a Post

Genomic and immunologic correlates of LAG-3 expression in cancer

Genomic and immunologic correlates of LAG-3 expression in cancer

Source :

https://www.tandfonline.com/doi/full/10.1080/2162402X.2020.1756116

Immune checkpoint blockade leads to impressive and durable responses in multiple cancer types, and at present, both PD-1 and CTLA-4 blockade have been FDA approved for the treatment of several cancer types.